Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/5682
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDecoster, G.-
dc.contributor.authorBUYSE, Marc-
dc.date.accessioned2007-12-20T16:01:03Z-
dc.date.available2007-12-20T16:01:03Z-
dc.date.issued1995-
dc.identifier.citationDrug information journal, 29. p. 79-86-
dc.identifier.urihttp://hdl.handle.net/1942/5682-
dc.titlePhase IV clinical trials: purpose, design and a limited place for GCP-
dc.typeJournal Contribution-
dc.identifier.epage86-
dc.identifier.spage79-
dc.identifier.volume29-
local.type.specifiedArticle-
dc.bibliographicCitation.oldjcat-
item.accessRightsClosed Access-
item.contributorDecoster, G.-
item.contributorBUYSE, Marc-
item.fullcitationDecoster, G. & BUYSE, Marc (1995) Phase IV clinical trials: purpose, design and a limited place for GCP. In: Drug information journal, 29. p. 79-86.-
item.fulltextNo Fulltext-
Appears in Collections:Research publications
Show simple item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.